Horizon Therapeutics plc to Participate in Upcoming Investor Conferences
DUBLIN--(BUSINESS WIRE)--Nov 13, 2019--
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following upcoming conferences:
Stifel 2019 Healthcare Conference
Jefferies 2019 London Healthcare Conference
Piper Jaffray 31 st Annual Healthcare Conference
The conference presentations will be webcast live and may be accessed by visiting Horizon’s website at http://ir.horizontherapeutics.com. A replay of the webcasts will be available for the events.
Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com, follow us @HorizonNews on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191113005859/en/
Senior Vice President,
Executive Vice President,
Corporate Affairs & Chief Communications Officer
KEYWORD: NEW YORK NORTH AMERICA UNITED STATES IRELAND UNITED KINGDOM EUROPE
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Horizon Therapeutics plc
Copyright Business Wire 2019.
PUB: 11/13/2019 04:15 PM/DISC: 11/13/2019 04:15 PM